These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 21285682)
1. Bone infarct-associated sarcoma detected on FDG PET/CT. Dua SG; Purandare N; Shah S; Sharma AR; Zade AA; Rangarajan V Clin Nucl Med; 2011 Mar; 36(3):218-20. PubMed ID: 21285682 [TBL] [Abstract][Full Text] [Related]
2. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas. Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673 [TBL] [Abstract][Full Text] [Related]
3. Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients? Walter F; Czernin J; Hall T; Allen-Auerbach M; Walter MA; Dunkelmann S; Federman N J Pediatr Hematol Oncol; 2012 Mar; 34(2):131-6. PubMed ID: 22134608 [TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575 [TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. Völker T; Denecke T; Steffen I; Misch D; Schönberger S; Plotkin M; Ruf J; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H J Clin Oncol; 2007 Dec; 25(34):5435-41. PubMed ID: 18048826 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of F-18 FDG PET/CT in a case of Kaposi sarcoma with an unexpected bone lesion. Morooka M; Ito K; Kubota K; Yanagisawa K; Teruya K; Hasuo K; Shida Y; Minamimoto R; Kikuchi Y; Oka S Clin Nucl Med; 2011 Mar; 36(3):231-4. PubMed ID: 21285687 [TBL] [Abstract][Full Text] [Related]
7. F-18 FDG PET/CT as a crucial guide toward optimal treatment planning in a case of postirradiation sarcoma 10 years after primary bone lymphoma of the pelvis. de Rooy JW; Hambrock T; Vriens D; Flucke UE; van der Geest IC; van de Luijtgaarden AC; Schreuder BW; de Geus-Oei LF Clin Nucl Med; 2011 Jul; 36(7):565-7. PubMed ID: 21637060 [TBL] [Abstract][Full Text] [Related]
8. Utilization of positron emission tomography in the management of patients with sarcoma. Benz MR; Tchekmedyian N; Eilber FC; Federman N; Czernin J; Tap WD Curr Opin Oncol; 2009 Jul; 21(4):345-51. PubMed ID: 19412096 [TBL] [Abstract][Full Text] [Related]
9. (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma. Al-Ibraheem A; Buck AK; Benz MR; Rudert M; Beer AJ; Mansour A; Pomykala KL; Haller B; Juenger H; Scheidhauer K; Schwaiger M; Herrmann K Cancer; 2013 Mar; 119(6):1227-34. PubMed ID: 23233156 [TBL] [Abstract][Full Text] [Related]
10. F-18 FDG PET-CT imaging in gastric sarcoma. Gamble B; Meka M; Ho L Clin Nucl Med; 2009 Sep; 34(9):564-5. PubMed ID: 19692814 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary artery sarcoma detected on F-18 FDG PET/CT as origin of multiple spinal metastases. Chun IK; Eo JS; Paeng JC; Kim DW; Chung JK; Lee DS Clin Nucl Med; 2011 Aug; 36(8):e87-9. PubMed ID: 21716007 [TBL] [Abstract][Full Text] [Related]
13. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw. Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572 [TBL] [Abstract][Full Text] [Related]
14. Role of PET/PET-CT in the management of sarcomas. Kumar R; Chauhan A; Vellimana AK; Chawla M Expert Rev Anticancer Ther; 2006 Aug; 6(8):1241-50. PubMed ID: 16925490 [TBL] [Abstract][Full Text] [Related]
15. Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT. Homann G; Mustafa DF; Ditt H; Spengler W; Kopp HG; Nikolaou K; Horger M Acad Radiol; 2015 Apr; 22(4):505-12. PubMed ID: 25586709 [TBL] [Abstract][Full Text] [Related]
16. Impact of PET and CT in PET/CT studies for staging and evaluating treatment response in bone and soft tissue sarcomas. Piperkova E; Mikhaeil M; Mousavi A; Libes R; Viejo-Rullan F; Lin H; Rosen G; Abdel-Dayem H Clin Nucl Med; 2009 Mar; 34(3):146-50. PubMed ID: 19352275 [TBL] [Abstract][Full Text] [Related]
17. Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas. Rakheja R; Makis W; Tulbah R; Skamene S; Holcroft C; Nahal A; Turcotte R; Hickeson M AJR Am J Roentgenol; 2013 Jul; 201(1):170-7. PubMed ID: 23789672 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185 [TBL] [Abstract][Full Text] [Related]
19. Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET. Huyge V; Garcia C; Vanderstappen A; Alexiou J; Gil T; Flamen P Clin Nucl Med; 2009 Jul; 34(7):417-20. PubMed ID: 19542943 [TBL] [Abstract][Full Text] [Related]
20. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer. Lee JW; Lee SM; Lee HS; Kim YH; Bae WK Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]